Business Segments Bolt Biotherapeutics, Inc.
Equities
BOLT
US0977022039
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.780 USD | +0.70% |
|
-8.54% | -45.99% |
| 06-06 | Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025 | RE |
| 05-12 | Bolt Biotherapeutics, Inc. - Special Call |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Biological Products | |||||||
Biotechnology (Startups) | 231K | 1.26M | 5.73M | 7.88M | 7.69M | ||
Total Assets | 46.54M | 308M | 228M | 160M | 99.63M | ||
CAPEX | -3.26M | -2.34M | -1.95M | -206K | -41K | ||
EBT | -60.73M | -98.59M | -88.1M | -69.2M | -63.12M | ||
D&A | 611K | 1.19M | 1.67M | 1.85M | 1.78M | ||
Operating Income | -49.18M | -92.79M | -90.32M | -76.2M | -73.05M | ||
Net Income | -60.73M | -98.59M | -88.1M | -69.2M | -63.12M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
United States | 231K | 1.26M | 5.73M | 7.88M | 7.69M | ||
Total Assets | 46.54M | 308M | 228M | 160M | 99.63M | ||
D&A | 611K | 1.19M | 1.67M | 1.85M | 1.78M | ||
CAPEX | -3.26M | -2.34M | -1.95M | -206K | -41K | ||
Net Income | -60.73M | -98.59M | -88.1M | -69.2M | -63.12M | ||
EBT | -60.73M | -98.59M | -88.1M | -69.2M | -63.12M | ||
Operating Income | -49.18M | -92.79M | -90.32M | -76.2M | -73.05M |
- Stock Market
- Equities
- BOLT Stock
- Financials Bolt Biotherapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition